The Vall d´Hebron Institute of Oncology (VHIO) Seeks a “ACADEMIC OFFICER”
Reference: Ref. 35-2022 SO
Application deadline: 15/07/2022
Number of vacancies: 1
VHIO has been awarded as a Center of Excellence Severo Ochoa, granted within the subprogram of the Spanish Institutional Strengthening of the State Plan for Scientific and Technical Research & Innovation, recognizes national research centers that demonstrate scientific leadership of excellence and impact at global level. The aid has been funded by the State Agency for Research (Agencia Estatal de Investigación) (CEX2020-001024-S / AEI / 10.13039 / 501100011033)
We are recruiting an enthusiastic and highly motivated Academic Officer to support the Academic and Training Programmes at the VHIO. The successful candidate will be responsible for implementing several activities and actions, ensuring high quality, efficient processes, and timely delivery. The Academic Officer will join the VHIO Academy Unit and, in close collaboration with the Head of the Unit and the Training Officer, will:
- Support the Head of the Unit in the coordination of VHIO international and national undergraduate, predoctoral and mobility fellowship programmes.
- Support the Training Officer in the organization of training activities.
- Plan and implement the activities related to the VHIO International Undergraduate, PhD, Postdoc, Mobility, MDs, and Outreach programmes (e.g., organizing meetings, symposia, retreats, drafting minutes, gathering data and reports, updating webpages, etc.).
- Support fellows during their incorporation process at VHIO and serve as liaison between them and the university where they are/will be enrolled (for undergraduate and predoctoral researchers).
- Setting-up and keeping up-to-date the young researchers’ database.
- Oversee dedicated budgets and expenses.
- You hold a Bachelor’s degree in a field appropriate to the area of assignment or you have any equivalent combination of education and/or experience from which comparable knowledge, skills and abilities have been achieved.
- You have experience in event organization and/or project management in an international research environment.
- Experience and/or familiar with the management of fellowship programmes will be a plus.
- Demonstrated effective organizational skills and the ability to work in an independent and proactive manner.
- Excellent interpersonal skills are essential for this position, as is the ability to establish effective channels of communication with a large variety of stakeholders.
- High degree of service orientation.
- Very good command (spoken and written) of English, Spanish and Catalan.
- Strong IT knowledge (user level)
Potential candidates should submit a curriculum vitae, letter of intent, and at least one reference using the form below or via email to firstname.lastname@example.org, including the reference “Ref. 35-2022” in the subject line of your email.
Under the leadership of Josep Tabernero, the Vall d’Hebron Institute of Oncology (VHIO), has established itself as a comprehensive cancer center of proven excellence internationally. It is also thanks to VHIO’s optimal organizational structure based on a purely multidisciplinary and translational model that VHIO talents continue to anticipate and tackle the many unresolved questions in combatting this multifaceted and heterogeneous disease.
Located within the Vall d’Hebron Barcelona Hospital Campus, our researchers closely collaborate and interact with Vall d’Hebron physician-scientists. Translational science and clinical research are therefore tightly connected which promotes superb interaction and teamwork which, in turn, accelerates the bench-bedside-bed cycle of knowledge. This privileged environment affords VHIO direct access to patients as well as the entire spectrum of oncology professionals who care for them, and a second-to-none appreciation of how cancer science can translate into more powerful, targeted treatments and better practice for the care of patients.
VHIO’s pioneering model and programs, coupled with its belief in combining strengths through cross-border collaborations, continue to spur advances in reversing cancer resistance, halting metastatic spread, and more effectively treating even the most undruggable tumor types